View in EDS

The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.

Saved in:
Bibliographic Details
Title: The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.
Authors: Sogi KM; School of Public Health, Division of Infectious Diseases and Vaccinology, Li Ka Shing Center, University of California , Berkeley, California 94720, United States., Lien KA; Department of Molecular and Cell Biology, University of California , Berkeley, California 94720, United States., Johnson JR; Department of Cellular and Molecular Pharmacology, University of California-San Francisco , San Francisco, California 94158, United States., Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California-San Francisco , San Francisco, California 94158, United States., Stanley SA; School of Public Health, Division of Infectious Diseases and Vaccinology, Li Ka Shing Center, University of California , Berkeley, California 94720, United States.; Department of Molecular and Cell Biology, University of California , Berkeley, California 94720, United States.
Source: ACS infectious diseases [ACS Infect Dis] 2017 Aug 11; Vol. 3 (8), pp. 564-574. Date of Electronic Publication: 2017 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2373-8227
DOI:10.1021/acsinfecdis.7b00046